Dr Molly Li received his medical degree (MBBS) from the University of Hong Kong in 2014 with distinction in medicine. He obtained specialist qualification in Medical Oncology in 2021 and joined …

Deuterium Switch (Replacing Hydrogen With Deuterium) Comes to Thoracic Oncology as Deuterated Lorlatinib (Deulorlatinib, TGRX-326) and Deuterated …

This is the research group of Dr Molly Li at Hong Kong Polytechnic University (PolyU). The group is working on the sustainable catalysis development with a focus on nanomaterials & catalysts application.

Hi 👋 I’m Molly! I’m passionate about technology and science. I graduated from Johns Hopkins University and am working as an Associate Computational Biologist at the Broad Institute of MIT and...

Dr Molly Li completed her PhD in Inorganic Chemistry in May 2018 from the University of Oxford.

ersity of Hong Kong Dr Molly Li is a thoracic medical oncologist who works as clinical assistant professor in the Chinese Univ. rsity of Hong Kong. His research interests in lung cancer include screening, …

Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative review. Transbronchial Techniques for Lung Cancer …

Dr Molly Li is a thoracic medical oncologist who works as clinical assistant professor in the Chinese University of Hong Kong. His research interests in lung cancer include screening, translational and …

Importance: Molecular testing in non-small cell lung cancer (NSCLC) is commonly limited by inadequate tumor sample. Plasma cell-free DNA (cfDNA) genotyping as a complementary test is specific but...

Aug 22, 2025 · Molly Li, MBBS, of the Chinese University of Hong Kong, joined Lung Cancers Today at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss key updates in …